Thrombosis after implantation of drug-eluting stents [7]

JAMA

Volumn 295, Issue 1, 2006, Pages 36-

  Marret, Emmanuel ^a   Collet, Jean Phillipe ^a   Albaladejo, Pierre ^a   Montalescot, Gilles ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; PACLITAXEL; RAPAMYCIN;

BLEEDING; DRUG ELUTING STENT; HOSPITAL ADMISSION; HUMAN; LETTER; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOSIS; TREATMENT PLANNING; VASCULAR SURGERY; NOTE; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; HUMANS; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; SIROLIMUS; STENTS; THROMBOSIS;

EID: 29944435681     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.1.36-a     Document Type: Letter

References (5)

1. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130.
2. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation. 2004;110:2361-2367.
3. Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol. 2005;45:456-459.
4. Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg. 2001;93:573-580.
5. Samama CM, Thiry D, Elalamy I, et al. Perioperative activation of hemostasis in vascular surgery patients. Anesthesiology. 2001;94:74-78.